STAT3 and breast carcinoma: IL-17 directly enhances the proliferation of keratinocytes, promotes MMP-dependent cell invasion, supports angiogenesis, inhibits TGF-β-dependent apoptosis, and enhances MEK-, ERK-, JNK-, and STAT3-mediated breast cancer cell proliferation[44].